Saint Francis ‘Robot’ Offers MS Patients Hope
Hartford Business - USA
Cummings is doing some of the work, building back muscles that his multiple sclerosis helped to atrophy. But the machine, called a Lokomat, is helping too. ...
See all stories on this topic

Antisense Therapeutics licenses ATL1102 to Teva
Trading Markets (press release) - Los Angeles,CA,USA
ANP also has the potential to receive payments related to the continued clinical development of ATL1102 for MS upon certain future development milestones, ...
See all stories on this topic

Scientists Find New Receptor for HIV
New York Times - United States
One candidate is a drug, Tysabri or natalizumab, that is marketed for treatment of multiple sclerosis, Dr. Fauci said. Biogen/Elan makes Tysabri. ...
See all stories on this topic

Biogen net income soars as Tysabri continues to grow
Pharma Times (subscription) - London,UK
Best of all, however, was the performance of the new MS drug Tysabri (natalizumab), which is partnered with Elan and only returned to the market in July ...
See all stories on this topic

NORTH INDIAN RIVER COUNTY LIBRARY: Author to give talk at library ...
TCPalm - West Palm Beach,FL,USA
Montel Williams gives us tools for "Living Well: 21 Days to Transform Your Life, Supercharge Your Health and Feel Spectacular." With specific directions for ...
See all stories on this topic

Acorda Therapeutics Reports Fourth Quarter and Full Year 2007 ...
Business Wire (press release) - San Francisco,CA,USA
We also initiated investments for the commercialization of Fampridine-SR, if approved,” said Ron Cohen, MD, President and Chief Executive Officer of Acorda ...
See all stories on this topic

Acorda reports Q4 loss
Business in the Burbs - White Plains,NY,USA
It is trying to develop Fampridine-SR, another drug for treatment of multiple sclerosis. This entry was posted by Allan Drury on Monday, February 11th, ...
See all stories on this topic

Therapeutic vaccine approach for Parkinson's disease
NTV - Kearney,NE,USA
Cop-1 has been used effectively in patients with chronic neuroinflammatory disease such as relapsing remitting multiple sclerosis for more than a decade. ...
See all stories on this topic

Myelin Repair Foundation Launches First-Of-A-Kind Drug Discovery Advisory Group
The Myelin Repair Foundation (MRF), a U.S.-based not-for profit medical research foundation focused on accelerating the rate of target identification and validation to speed drug discovery and development, has launched a first-of-a-kind Drug Discovery Advisory Group (DDAG).
'New aspirin' vitamin D isn't understood
UPI Fri, 08 Feb 2008 10:40 AM PST
Vitamin D may guard against heart disease, osteoporosis, multiple sclerosis and cancer but its effects aren't completely understood, a Canadian researcher says.

Drugmaker Biogen Idec 4Q Profit Surges
The Associated Press -
On a conference call with analysts Wednesday, Biogen Idec Chief Executive James Mullen said no buyers emerged because risks surrounding the MS drug Tysabri ...
See all stories on this topic

Billy Talent Drummer Acts As Driving Force Behind MS Scholarship Program, Canada
The Multiple Sclerosis Society of Canada announced that for the second year in a row, scholarship applications are now available for youth directly impacted by MS. The drummer of one of Canada's hottest punk rock bands, Billy Talent, is the driving force behind the program.

Billy Talent Drummer Acts As Driving Force Behind MS Scholarship Program, Canada
Medical News Today Fri, 08 Feb 2008 5:15 AM PST
The Multiple Sclerosis Society of Canada announced that for the second year in a row, scholarship applications are now available for youth directly impacted by MS. The drummer of one of Canada's hottest punk rock bands, Billy Talent, is the driving force behind the program.

Vitamin D for cancer
News-Medical-Net Thu, 07 Feb 2008 5:24 PM PST
It sounds too good to be true … a little inexpensive pill that could block the development of some cancers, strengthen bones, prevent multiple sclerosis and alleviate winter depression.